Daré Bioscience, Inc. (DARE)
NASDAQ: DARE · Real-Time Price · USD
0.7400
-0.0302 (-3.92%)
Sep 2, 2026, 4:00 PM EDT - Market closed

Daré Bioscience Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
1128273070153
Market Cap Growth
-58.40%1.59%-10.87%-56.74%-54.05%178.42%
Enterprise Value
513171731108
Last Close Price
0.741.933.123.719.9624.00

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
8.2826.772774.4510.857.04-
PB Ratio
-9.70-4.51-6.036.343.95
P/TBV Ratio
-9.70--6.343.95
P/FCF Ratio
--5.54---
P/OCF Ratio
--4.96---

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
4.0012.301769.855.973.06-
EV/FCF Ratio
--3.53---

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
-12.082.83-1.01-0.280.040.01
Debt / FCF Ratio
--1.24---
Net Debt / Equity Ratio
10.45-5.861.601.80-3.08-1.33
Net Debt / EBITDA Ratio
0.651.400.410.301.091.32
Net Debt / FCF Ratio
0.501.62-1.970.231.881.79
Asset Turnover
0.080.0400.090.20-
Quick Ratio
0.751.070.740.561.153.29
Current Ratio
0.991.140.850.861.363.45
Return on Equity (ROE)
----994.69%-124.12%-205.82%
Return on Assets (ROA)
-39.29%-31.04%-67.57%-59.02%-39.38%-77.08%
Return on Capital Employed (ROCE)
-204.00%-154.20%-4805.00%-3834.00%-257.20%-98.30%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-97.11%-48.59%-14.93%-99.03%-43.96%-25.26%
FCF Yield
-103.90%-37.24%18.05%-129.65%-25.78%-18.79%
Buyback Yield / Dilution
-62.78%-31.55%-16.80%-3.23%-38.29%-103.23%
SEC Filings: 10-K · 10-Q